CBPE Capital, a private equity investment firm, completed the investment in Veincentre, a provider of venous insufficiency treatments, primarily for varicose veins. Financial terms were not disclosed. “Patients come to us because they know we are the dedicated experts in treating venous reflux disorder. In CBPE we have found an investor with an equal passion for the business and a strong track record in growing multi-site healthcare businesses. We are excited for what the future holds for Veincentre," Maurice McLoughlin, Veincentre CEO.